GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
‘You are not safe if only your citizens are vaccinated’
Experts warn developed countries against COVID-19 Nationalism Experts have warned developed countries currently overstocking the COVID-19 vaccine for exclusive vaccination of their citizens not to consider their shores safe from
UNAIDS partners ABCHealth to end HIV/AIDS epidemic in Nigeria
To ensure an end to HIV/AIDS epidemic in Nigeria, the Joint United Nations Programme on HIV/AIDS, UNAIDS, and a corporate group, the African Business Coalition for Health, ABCHealth, Thursday, signed
Police parade former Kwara General Hospital CMD for multiple killings
Kwara State Police Command Monday, paraded the former Chief Medical Director of Government General hospital in Kaima area of the state Dr Abass Adio Adeyemi, over multiple killings of six
0 Comments
No Comments Yet!
You can be first to comment this post!